10 High levels of nitric oxide can contribute to oxidative stress
Preparing PT-141 nasal spray Why nasal spray: Avoids injections (needle-phobic) More convenient Slightly faster onset (30-60 min quicker) Lower bioavailability (~30% vs ~100% injection) Need higher dose to compensate Nasal spray supplies needed: Empty nasal spray bottle (10-15ml) Reconstituted PT-141 (higher concentration recommended) Syringe for transferring Small funnel (optional) Concentration for nasal spray: Higher concentration better (less volume per dose) Reconstitute 10mg PT-141 in 1ml water = 10mg/ml Or even 10mg in 0.5ml = 20mg/ml (very concentrated) Allows smaller spray volume Fewer sprays needed per dose Nasal spray dosing: Inject: 1.5mg dose Nasal equivalent: 3-5mg (lower absorption) 0.3ml of 10mg/ml concentration = 3mg nasal 0.5ml of 10mg/ml = 5mg nasal Typical: 2-3 sprays per nostril (0.1ml per spray) See complete PT-141 nasal spray guide for men for detailed protocols
Reported benefits (per available research): Reliably studied for its ability to increase circulating growth hormone (and downstream IGF-1) in both animal models and a human Phase II trial, where it was well tolerated but did not significantly outperform placebo on its primary clinical endpoint Studied in rodent models for effects on bone formation and bone mineral content, including in a glucocorticoid-induced bone-loss model, though this evidence is animal-only and has not been confirmed in controlled human trials Anecdotally and in early/limited research associated with changes in body composition (lean mass, fat mass) and subjective sleep quality, but these claims rely mostly on user reports and small or non-peer-reviewed data rather than robust human clinical trials Known risks and side effects: FDA safety reviewers flagged growth-hormone-secretagogue peptides in this family for potential cardiovascular effects (e.g., increased heart rate, vasodilatory reactions such as flushing and transient hypotension) as part of the rationale for restricting compounding Commonly reported effects include headache, injection-site reactions, and mild fluid retention or bloating tied to growth-hormone-mediated fluid balance changes Because it is sold as an unregulated research chemical outside pharmaceutical manufacturing controls, there is added risk from impurities, mislabeled concentration, and lack of quality assurance, and long-term human safety data remain limited or absent Evidence snapshot: The strongest human evidence is a randomized, double-blind, placebo-controlled Phase II trial (ClinicalTrials.gov NCT00672074) in bowel-resection patients showing ipamorelin was well tolerated but not significantly more effective than placebo for postoperative ileus
And yet we are engaging less of this physical activity that we need as a species
Zafalon RVA, Risolia LW, Vendramini THA, et al
Some users experience a temporary shedding chase as old hairs make way for new growth
